In prostate cancer, LSD1 binds to the promoter region of VEGF-A (vascular endothelial growth factor A) to regulate the protein level via AR, and VEGF-A partially promotes cell invasion and metastases by inducing epithelial–mesenchymal transition.87 This evidence concerns the gene VEGFA and prostate carcinoma.